Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tempus CRC Surveillance Study: A Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Colorectal Cancer (CRC) Using Comprehensive Next-Generation Sequencing (NGS)Assays

NCT05234177 is registered in ClinicalTrials.gov with Tempus AI as lead sponsor.

NCT NCT05234177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05234177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tempus CRC Surveillance Study: A Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Colorectal Cancer (CRC) Using Comprehensive Next-Generation Sequencing (NGS)Assays
Lead sponsor
Tempus AI
Phase
Observational
Overall status
Recruiting
Start date
June 21, 2022
Completion date
February 28, 2029
Enrollment
300 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer